Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Aethlon Medical, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
aethlonmedical.comAI Executive Summary
AI-powered analysis of 8-K filing content
Aethlon Medical stockholders approved an amendment to the 2020 Equity Incentive Plan on October 1, 2026, increasing authorized shares by 100,000 to enhance employee incentive capacity through stock options.
Key Takeaways
Stockholders approved a 100,000 share increase to the 2020 Equity Incentive Plan at the Annual Meeting on October 1, 2026
The Board of Directors had previously approved this amendment on July 10, 2026, contingent on stockholder approval
2 more takeaways
Related Filings (1)
1 more filing from Aethlon Medical, Inc. in the last 90 days
Filing Overview
What This Means
Aethlon Medical, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.